About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Michigan | 20,100 Studies Near You

Clinical TrialsMichigan

Clinical Trials in Michigan

Discover 20,100 clinical trials near Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 2041-2060 of 20,100 trials

CompletedA Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic HypersomniaThe primary objective of this study is to assess the long-term safety and effectiveness of pitolisant in patients with idiopathic hypersomnia (IH) who completed the Double-Blind…NCT05458128·Los Angeles, California and 31 others

Find Trials by Condition in Michigan

Breast Cancerin Michigan Lung Cancerin Michigan Prostate Cancerin Michigan Colorectal Cancerin Michigan Melanomain Michigan Leukemiain Michigan Lymphomain Michigan Pancreatic Cancerin Michigan Ovarian Cancerin Michigan Brain Cancerin Michigan Diabetes

Data from ClinicalTrials.govTerms

CompletedImplantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMSThis is a prospective, post-market, multi-center, non-blinded, single arm study of the HeartMate 3 Left Ventricular Assist System (LVAS).NCT04548128·Little Rock, Arkansas and 31 others

CompletedEfficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With MetforminPrimary Objective: To demonstrate the superiority of Sotagliflozin 400 milligrams (mg) versus placebo on Hemoglobin A1c (HbA1c) reduction at Week 26 in participant with type 2…NCT03066830·Litchfield Park, Arizona and 75 others

TerminatedGRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)The purpose of this study is to assess the efficacy, safety, and tolerability of GRN1005 in patients with brain metastases from non-small cell lung cancer (NSCLC).NCT01497665·La Jolla, California and 9 others

CompletedLutrePulse Hypogonadotropic HypogonadismTo compare the ovulation rate in women with primary amenorrhea with hypogonadotropic hypogonadism following pulsatile gonadotropin-releasing hormone (GnRH) treatment using the…NCT01976728·Tempe, Arizona and 34 others

RecruitingThe Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell DiseaseThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, flexible-adaptive, group-sequential study (Part A), followed by an open-label LTE period (Part…NCT06975865·Birmingham, Alabama and 62 others

RecruitingA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaThis study is researching an experimental drug called odronextamab, referred to as study drug, when used in combination with chemotherapy.NCT06091865·Scottsdale, Arizona and 194 others

CompletedDose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis ComplexThe study aims to compare the safety and efficacy of two different strengths of Rapamycin cream, topical and placebo over 26 weeks in the treatment of facial angiofibroma (FA)…NCT03826628·Phoenix, Arizona and 16 others

UnknownClinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic BronchitisThis is a prospective, randomized, parallel group, double-blind, sham-controlled, multicenter clinical trial following patients to 2 years.NCT04677465·Birmingham, Alabama and 36 others

Active not recruitingRibociclib and Bicalutamide in AR+ TNBCThis is an open label, multi-institutional, single arm phase II trial of ribociclib in combination with bicalutamide in advanced AR+ triple-negative breast cancer.NCT03090165·Chicago, Illinois and 5 others

CompletedWill Veterans Engage in Prevention After HRA-guided Shared Decision Making?The VA has committed to disseminate a web-based Healthy Living Assessment(HLA) tool and use it as the cornerstone of a personalized prevention plan to engage patients to improve…NCT01828567·Ann Arbor, Michigan and 1 other

CompletedStudy of Evinacumab (REGN1500) in Participants With Persistent HypercholesterolemiaThe primary objective of the study is to evaluate the reduction of LDL-C by evinacumab in comparison to placebo after 16 weeks in patients with primary hypercholesterolemia (HeFH…NCT03175367·Los Angeles, California and 94 others

CompletedPalm Tocotrienols in Chronic Hemodialysis (USA)Patients undergoing chronic hemodialysis are at increased risk for cardiovascular disease, attributed in part to increased oxidative stress, inflammation and dyslipidemia.NCT02358967·Detroit, Michigan

RecruitingZanzalintinib for the Treatment of Advanced Thyroid Cancer Before SurgeryTo look at the effectiveness of zanzalintinib, followed by surgery, in treating advanced thyroid cancer. The safety of this treatment will also be studied.NCT06959511·Boston, Massachusetts and 4 others

CompletedTiotropium (Spiriva) Rehabilitation StudyThe study was designed to determine whether tiotropium inhalation capsules, compared to placebo, enhances the improvement in exercise tolerance seen in patients with chronic…NCT00274521·Birmingham, Alabama and 18 others

CompletedA Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002), given monthly for 6 doses, in…NCT04322604·Birmingham, Alabama and 59 others

CompletedS9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.NCT00003784·Mobile, Alabama and 86 others

TerminatedLaboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT01022138·Detroit, Michigan

CompletedBEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerThe main objective of the trial is to compare Invasive Disease-Free Survival (IDFS) of patients randomised to treatment with adjuvant chemotherapy alone or to adjuvant…NCT00528567·Huntsville, Alabama and 402 others

CompletedGlaucoma BiomarkersGlaucoma is a major cause of blindness.NCT01677507·Ann Arbor, Michigan and 2 others

PreviousPage 103 of 1005Next

in Michigan

Heart Diseasein Michigan